Obstetric anesthesia

Impact of Neuraxial Preservative-Free Morphine in Vaginal Delivery on Opiate Consumption and Recovery: A Randomized Control Trial

Anesth AnalgPublished Randomised controlled trial

Authors' conclusion

A single epidural dose of 2 mg preservative-free morphine after VD was effective at decreasing pain and opioid use at 24 hours after VD but came at the cost of increased pruritus.

Study context

Population
Parturients who delivered vaginally with epidural analgesiaanalysed
Participants
157 participants
Comparison
Morphine vs Saline
  • Morphinen = 80
  • Salinen = 77reference
Primary endpoint
Opiate consumption
Follow-up
First 24 hours after drug administration

Primary result

As reported in the abstract

Opioid use · first 24 hours

Secondary outcomes

OutcomeMorphineSalineP value
Total opioid dose (MME) · first 24 hoursmedian 0 (IQR [range] 0-0 [0-47.5]) morphine milligram equivalentmedian 0 (IQR [range] 0-0 [0-72]) morphine milligram equivalentP = 0.023
Verbal pain scores (0-10) · 24 hoursLower in the morphine group · median2.0 (IQR [range] 1-4 [0-10])3.0 (IQR [range] 1.5-5.0 [0-10])P = 0.043

OBS-QOR10, breastfeeding (BF) success, Edinburgh Postnatal Depression Score (EPDS) · 6 weeks PP

No differences found

Safety

OutcomeMorphineSalineP value
Pruritus37.5% (95% CI 27.1%–49.1%)18.2% (95% CI 10.6%–29.0%)P = 0.008

Original publication

Impact of Neuraxial Preservative-Free Morphine in Vaginal Delivery on Opiate Consumption and Recovery: A Randomized Control Trial. Anesth Analg. Published 1 May 2025. doi:10.1213/ane.0000000000006987

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.